GSK to advance antibody medicines for neurodegenerative diseases
The licensing agreement will support development of medicines for delivery…
The licensing agreement will support development of medicines for delivery across the blood-brain barrier to treat neurological disorders like Alzheimer’s and Parkinson’s.